Suchergebnisse - "Chilton, Robert J"

PubPharm (10)

1

Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes

enthalten in: Diabetes, obesity & metabolism | 2023

von Moody, A. | Molina-Wilkins, M. | Clarke, G. | +8

2

SGLT2 inhibitors : a narrative review of efficacy and safety

enthalten in: Journal of osteopathic medicine | 2021

von Nelinson, D. | Sosa, J. | Chilton, R.

3

Cardiovascular risk and the implications for clinical practice of cardiovascular outcome trials in type 2 diabetes

enthalten in: Primary care diabetes | 2020

von Chilton, R. | Dungan, K. | Shubrook, J. | +1

4

Cardiorenal protection with SGLT2 : Lessons from the cardiovascular outcome trials

enthalten in: Journal of diabetes | 2020

von Silva-Cardoso, J. | Sheikh, O. | Nashawi, M. | +4

5

Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetes

enthalten in: Diabetes, obesity & metabolism | 2020

von Chilton, R.

6

Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes

enthalten in: Diabetes care | 2017

von Clarke, G. | Solis-Herrera, C. | Molina-Wilkins, M. | +8

7

EMPA-REG OUTCOME : The Cardiologist's Point of View

enthalten in: The American journal of cardiology | 2017

von Pham, S. | Chilton, R.

8

The cardiovascular effects of GLP-1 receptor agonists

enthalten in: Cardiovascular therapeutics | 2012

von Okerson, T. | Chilton, R.

9

PROactive : time for a critical appraisal

enthalten in: European heart journal | 2008

von Betteridge, D. | DeFronzo, R. | Chilton, R.

10

Type 2 diabetes, cardiovascular risk, and the link to insulin resistance

enthalten in: Clinical therapeutics | 2003

von Stolar, M. | Chilton, R.

1
[1]